ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 58 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $19,000 | -83.9% | 13,463 | -60.3% | 0.00% | -91.2% |
| Q1 2019 | $118,000 | +13.5% | 33,928 | -25.0% | 0.03% | +30.8% |
| Q4 2018 | $104,000 | +141.9% | 45,211 | +226.1% | 0.03% | +160.0% |
| Q1 2016 | $43,000 | -49.4% | 13,864 | -30.7% | 0.01% | -28.6% |
| Q2 2015 | $85,000 | – | 20,005 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Values First Advisors, Inc. | 250,110 | $528,000 | 0.51% |
| XTX MARKETS LLC | 12,925 | $27,000 | 0.19% |
| Cornerstone Capital, Inc. | 491,560 | $1,037,000 | 0.15% |
| Aristides Capital LLC | 64,482 | $136,000 | 0.10% |
| LINCOLN CAPITAL CORP | 57,000 | $120,000 | 0.09% |
| HighVista Strategies LLC | 41,400 | $87,000 | 0.07% |
| Ahrens Investment Partners LLC | 61,500 | $130,000 | 0.05% |
| J Arnold Wealth Management Co | 18,000 | $38,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 114,437 | $241,000 | 0.03% |
| Avidian Wealth Solutions, LLC | 63,000 | $133,000 | 0.02% |